ABVC Historical Financial Ratios
| ABVC Stock | USD 3.01 0.51 14.49% |
ABVC Biopharma is presently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 5.67 or Days Sales Outstanding of 608 will help investors to properly organize and evaluate ABVC Biopharma financial condition quickly.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. About ABVC Financial Ratios Analysis
ABVC BiopharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate ABVC Biopharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on ABVC financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across ABVC Biopharma history.
ABVC Biopharma Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing ABVC Biopharma stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ABVC Biopharma sales, a figure that is much harder to manipulate than other ABVC Biopharma multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from ABVC Biopharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into ABVC Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.At present, ABVC Biopharma's Average Inventory is projected to increase significantly based on the last few years of reporting. The current year's Income Quality is expected to grow to 0.36, whereas Price To Sales Ratio is forecasted to decline to 13.67.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 1.06 | 1.1 | 0.26 | 0.25 | Revenue Per Share | 0.31 | 0.0352 | 0.041 | 0.0431 |
ABVC Biopharma fundamentals Correlations
Click cells to compare fundamentals
ABVC Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ABVC Biopharma fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 653.61 | 238.71 | 20.41 | 32.99 | 14.38 | 13.67 | |
| Ptb Ratio | 91.82 | 9.6 | 6.39 | 0.6 | 5.97 | 5.67 | |
| Days Sales Outstanding | 755.17 | 1.8K | 515.44 | 1.8K | 828.56 | 608.37 | |
| Book Value Per Share | 1.35 | 3.54 | 1.14 | 1.88 | 0.0584 | 0.0613 | |
| Free Cash Flow Yield | (0.0145) | (0.0897) | (0.38) | (0.85) | (0.25) | (0.26) | |
| Operating Cash Flow Per Share | (1.79) | (2.31) | (3.03) | (2.34) | (0.98) | (0.15) | |
| Stock Based Compensation To Revenue | 8.59 | 14.92 | 7.26 | 10.73 | 12.34 | 11.72 | |
| Pb Ratio | 91.82 | 9.6 | 6.39 | 0.6 | 5.97 | 5.67 | |
| Ev To Sales | 658.19 | 231.07 | 23.47 | 47.54 | 18.67 | 17.74 | |
| Free Cash Flow Per Share | (1.79) | (2.31) | (3.04) | (2.37) | (0.98) | (0.15) | |
| Roic | (0.91) | (1.02) | (2.52) | (0.81) | (1.66) | (1.58) | |
| Inventory Turnover | 140.58 | (0.0422) | (0.0223) | 0.2 | 0.22 | 0.19 | |
| Net Income Per Share | (5.37) | (4.8) | (5.15) | (2.43) | (0.4) | (0.41) | |
| Days Of Inventory On Hand | (8.6K) | (16.4K) | 1.9K | 1.7K | 1.9K | 1.4K | |
| Sales General And Administrative To Revenue | 17.43 | 31.07 | 13.51 | 45.95 | 9.89 | 9.4 | |
| Research And Ddevelopement To Revenue | 1.14 | 2.82 | 2.78 | 6.97 | 0.35 | 0.33 | |
| Cash Per Share | 2.17 | 2.37 | 0.0509 | 0.0322 | 0.0252 | 0.024 | |
| Pocfratio | (69.18) | (11.18) | (2.67) | (1.19) | (4.05) | (4.25) | |
| Interest Coverage | (21.0) | (49.93) | (51.42) | (3.3) | (5.7) | (5.98) | |
| Pfcf Ratio | (69.18) | (11.15) | (2.63) | (1.18) | (4.05) | (4.25) | |
| Income Quality | 0.43 | 0.63 | 0.45 | 0.4 | 0.34 | 0.36 | |
| Roe | (3.08) | (1.36) | (5.26) | (1.25) | (4.0) | (3.8) | |
| Ev To Operating Cash Flow | (69.66) | (10.82) | (3.08) | (1.71) | (5.25) | (5.51) | |
| Pe Ratio | (29.8) | (7.06) | (1.21) | (0.48) | (1.49) | (1.57) | |
| Return On Tangible Assets | (0.91) | (0.88) | (1.66) | (0.73) | (0.65) | (0.68) | |
| Ev To Free Cash Flow | (69.66) | (10.8) | (3.03) | (1.7) | (5.25) | (5.51) | |
| Earnings Yield | (0.0336) | (0.14) | (0.82) | (2.09) | (0.67) | (0.7) | |
| Net Debt To E B I T D A | (0.21) | 0.25 | (0.2) | (0.27) | (0.5) | (0.53) | |
| Current Ratio | 1.27 | 2.61 | 0.51 | 0.28 | 0.33 | 0.32 | |
| Tangible Book Value Per Share | 1.35 | 3.54 | 1.14 | 1.88 | 0.0584 | 0.0613 | |
| Shareholders Equity Per Share | 1.74 | 3.53 | 0.98 | 1.93 | 0.0988 | 0.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.19) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.